SHEN26 |
| カタログ番号GC71336 |
SHEN26 (ATY014)は要り及び口頭活性RdRp拮抗薬とIC50なんかもってきてSARS-CoV-2 136μM。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2691076-98-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
SHEN26 (ATY014) is a potent and orally active RdRp inhibitor, with an IC50 for SARS-CoV-2 is 1.36 μM. SHEN26 is a 5’-cyclohexanecarboxylate derivative of GS-441524 . SHEN26 inhibits viral nucleic acid synthesis to achieve antiviral effects. SHEN26 can be used for the research of coronavirus disease 2019 (COVID-19).
IC50 of SHEN26 (ATY014) against variants of beta and delta are 1.12 μM and 0.35 μM[1].
Review for SHEN26
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for SHEN26
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *